P.S. Mitrou
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research
Papers in
- Hematology 18
- Acute Myeloid Leukemia Research 18
-
- Lymphoma Diagnosis and Treatment 9
- Co-authors
- David T. Hoelzer (15 shared papers)Lothar Bergmann (11 shared papers)Eckhart Weidmann (9 shared papers)Klaus Fenchel (4 shared papers)Jürgen Brieger (4 shared papers)Bernhard Jahn (2 shared papers)Ulrich Maurer (2 shared papers)Simone Boehrer (3 shared papers)
In The Last Decade
P.S. Mitrou
43 papers receiving 528 citations
Peers
Comparison fields: 5 of 43
- Hematology 203
- Genetics 71
- Pathology and Forensic Medicine 66
- Immunology 54
- Oncology 55
Countries citing papers authored by P.S. Mitrou
This map shows the geographic impact of P.S. Mitrou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P.S. Mitrou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P.S. Mitrou more than expected).
Fields of papers citing papers by P.S. Mitrou
This network shows the impact of papers produced by P.S. Mitrou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P.S. Mitrou. The network helps show where P.S. Mitrou may publish in the future.
Co-authors
The 25 scholars most cited alongside P.S. Mitrou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The expression of the Wilms' tumor gene in acute myelocytic leukemias as a possible marker for leukemic blast cells. | 1994 | 104 |
| 2 | The Wilms' tumor gene is expressed in a subset of CD34+ progenitors and downregulated early in the course of differentiation in vitro. | 1997 | 95 |
| 3 | 1993 | 79 | |
| 4 | In vitro induction of apoptosis of neoplastic cells in low-grade non-Hodgkin's lymphomas using combinations of established cytotoxic drugs with bendamustine. | 2001 | 57 |
| 5 | 1993 | 22 | |
| 6 | 1984 | 20 | |
| 7 | 1985 | 20 | |
| 8 | 1979 | 18 | |
| 9 | 1984 | 16 | |
| 10 | 2005 | 13 | |
| 11 | 1988 | 11 | |
| 12 | 2009 | 10 | |
| 13 | 1990 | 9 | |
| 14 | 1995 | 7 | |
| 15 | 1974 | 6 | |
| 16 | 1995 | 6 | |
| 17 | 1972 | 5 | |
| 18 | The oncogenic effect of immunosuppressive (cytotoxic) agents in (NZB X NZW) mice. I. Long-term treatment with azathioprine and ifosfamide. | 1979 | 5 |
| 19 | 1982 | 5 | |
| 20 | 1984 | 5 |
About P.S. Mitrou
P.S. Mitrou is a scholar working on Hematology, Pathology and Forensic Medicine, Oncology, Genetics and Pulmonary and Respiratory Medicine, having authored 56 papers that have together received 569 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (18 papers), Lymphoma Diagnosis and Treatment (9 papers), Lung Cancer Diagnosis and Treatment (4 papers), Chronic Lymphocytic Leukemia Research (4 papers), Lung Cancer Research Studies (3 papers), Hematological disorders and diagnostics (3 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Vasculitis and related conditions (2 papers). The work is most often cited by research in Hematology (203 citations), Genetics (71 citations), Pathology and Forensic Medicine (66 citations), Immunology (54 citations) and Oncology (55 citations). P.S. Mitrou has collaborated with scholars based in Germany and Austria. Frequent co-authors include David T. Hoelzer, Lothar Bergmann, Eckhart Weidmann, Klaus Fenchel, Jürgen Brieger, Bernhard Jahn, Ulrich Maurer, Simone Boehrer, Dieter F. Hoelzer and Kai Uwe Chow. Their work appears in journals such as Annals of Hematology, Cancer Treatment Reviews, Acta Haematologica, Annals of Oncology and Pharmacological Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.